New Delhi, July 17: NITI Aayog has presented an ambitious roadmap aimed at transforming India into one of the world’s leading biotechnology driven economies by 2047. The strategy envisions expanding the country’s bioeconomy to $691 billion by 2035 and further to $2.6 trillion by 2047, supported by coordinated policy reforms, technological innovation, and large scale investments.
The roadmap, titled “Roadmap for Building India as a Leading BioEconomy Powerhouse by 2035,” outlines a comprehensive framework to strengthen India’s biotechnology ecosystem while creating new opportunities for employment, industrial growth, healthcare innovation, agriculture, and sustainable manufacturing.
Bioeconomy Positioned as a Key Growth Engine
The report defines the bioeconomy as an economic system that relies on renewable biological resources to produce food, healthcare solutions, industrial materials, chemicals, biofuels, and clean energy products. It states that advances in biotechnology will become one of the defining pillars of India’s long-term economic transformation.
According to NITI Aayog, India’s bioeconomy has witnessed remarkable expansion over the last decade. The sector has grown from nearly USD 10 billion in 2014 to USD 195.3 billion in 2025, accounting for approximately 4.8 percent of the country’s Gross Domestic Product (GDP).
Officials believe this momentum can accelerate further through coordinated national action involving government institutions, private industry, research organisations, universities, and startup ecosystems.
Mission-Driven Implementation Recommended
The policy document recommends shifting from isolated initiatives toward an integrated national implementation framework capable of delivering faster outcomes.
To achieve this objective, the report proposes the creation of dedicated BioMissions focused on priority sectors such as healthcare biotechnology, industrial biotechnology, agricultural biotechnology, synthetic biology, and advanced bio-manufacturing.
These mission oriented programmes would receive coordinated policy support while enabling collaboration across multiple ministries responsible for science, health, agriculture, environment, industry, and education.
The roadmap suggests that a unified governance structure would significantly improve implementation speed and reduce duplication of efforts across government agencies.
Cross-Ministerial Coordination to Drive Growth
Recognising that biotechnology intersects multiple sectors, NITI Aayog recommends establishing empowered coordination mechanisms that bring together different ministries under a common execution platform.
Such institutional coordination would facilitate faster policy decisions, improve resource allocation, and strengthen implementation of national biotechnology programmes.
The report argues that a unified administrative approach will help India respond more effectively to rapidly evolving global technological developments.
Regulatory Reforms to Accelerate Innovation
One of the major recommendations involves simplifying India’s biotechnology regulatory framework while maintaining high standards of safety, ethics, and environmental protection.
The report notes that lengthy approval processes often delay research, commercialization, and investment decisions.
It therefore proposes modern regulatory systems capable of encouraging innovation without compromising public confidence.
Faster approvals for biotechnology products, research activities, clinical applications, and industrial manufacturing could significantly improve India’s competitiveness in global biotechnology markets.
Investment Push Through BioEconomy Growth Fund
To support large-scale innovation and industrial expansion, NITI Aayog recommends establishing a ₹50,000 crore BioEconomy Growth Fund.
The proposed fund would finance biotechnology startups, research institutions, pilot manufacturing facilities, infrastructure projects, and commercialization of scientific discoveries.
Financial assistance would also encourage private investment in emerging biotechnology segments while reducing funding constraints faced by early-stage enterprises.
Officials believe sustained investment will strengthen domestic manufacturing capabilities and reduce dependence on imported biotechnology products.
AI to Transform Biotechnology
A central theme of the roadmap is the convergence of biotechnology with artificial intelligence and advanced digital technologies.
The report highlights that future scientific breakthroughs will increasingly depend on integrating AI with genomics, computational biology, robotics, biosensors, machine learning, and precision manufacturing.
AI-powered research can significantly reduce drug discovery timelines, improve disease diagnosis, accelerate agricultural innovation, and optimise industrial biotechnology processes.
NITI Aayog believes this technological convergence will define the next phase of global biotechnology leadership.
Building a Skilled Biotechnology Workforce
The roadmap emphasises that achieving long-term success requires substantial investment in education, scientific research, and workforce development.
It recommends expanding bioscience education, strengthening university-industry partnerships, increasing research funding, and encouraging interdisciplinary training.
India will require thousands of additional researchers, engineers, laboratory professionals, bioinformatics experts, and biotechnology entrepreneurs to support the anticipated expansion of the sector.
Developing a highly skilled talent pool is viewed as one of the most critical enablers of sustained growth.
Employment Opportunities Expected to Rise
If implemented successfully, the proposed strategy could generate more than 30 million high-value jobs across biotechnology related industries.
Employment opportunities are expected to emerge in pharmaceuticals, healthcare, agriculture, diagnostics, vaccine development, food technology, renewable energy, bio-based chemicals, environmental management, and advanced manufacturing.
The report notes that biotechnology driven industries often create highly skilled, innovation based employment capable of supporting long-term economic productivity.
Global Competition Intensifies
NITI Aayog also draws attention to increasing international competition in biotechnology.
According to the report, major economies are investing aggressively to strengthen their biotechnology capabilities.
The United States has adopted comprehensive national strategies focused on advanced biomanufacturing and innovation.
The European Union is integrating biotechnology into its industrial competitiveness and climate transition policies.
China continues expanding biotechnology investments through long-term industrial planning supported by significant public funding.
Against this backdrop, the report argues that India must accelerate implementation to remain globally competitive.
India’s Opportunity in the Biological Century
Speaking during the release of the report, NITI Aayog Member Gobardhan Das said India has entered a transformative period for biotechnology.
He observed that many experts now compare the current biotechnology revolution with the emergence of the computing industry during the 1970s.
According to him, India possesses strong scientific capabilities, an expanding startup ecosystem, growing manufacturing strength, and increasing digital infrastructure that together create favourable conditions for rapid biotechnology expansion.
He described the present decade as a defining period that could determine India’s global leadership position in biotechnology for decades to come.
Innovation Ecosystem to Drive Future Growth
The roadmap stresses stronger collaboration among government agencies, research institutions, universities, biotechnology companies, venture capital investors, and startups.
It recommends encouraging technology transfer, strengthening intellectual property frameworks, supporting commercial research, and expanding international scientific cooperation.
A vibrant innovation ecosystem, the report argues, will help accelerate commercialization of research while attracting global investment into India’s biotechnology sector.
Long-Term Vision for Economic Transformation
NITI Aayog concludes that biotechnology will play a central role in India’s transition toward a knowledge-based, innovation-driven economy.
Beyond healthcare and pharmaceuticals, biotechnology is expected to influence agriculture, climate resilience, sustainable manufacturing, food security, environmental conservation, and renewable energy production.
With timely policy implementation, strategic investments, regulatory modernization, and technological advancement, the report projects that India can establish itself among the world’s top three biotechnology powers while building a resilient bioeconomy capable of supporting inclusive and sustainable economic growth over the coming decades.